Coagulation Changes Associated With COVID-19 Infection
NCT04460664 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15
Last updated 2022-05-13
Summary
This study will study the potential utility of the Quantra QPlus System in patients inflicted with COVID-19 disease.
Conditions
- COVID
- Disseminated Intravascular Coagulation
- Coagulation Disorder
Interventions
- DIAGNOSTIC_TEST
-
Quantra System
Diagnostic device to monitor coagulation properties of a whole blood sample at the point-of-care.
Sponsors & Collaborators
-
HemoSonics LLC
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-08-14
- Primary Completion
- 2021-04-28
- Completion
- 2022-01-26
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Anticoagulation in Patients Suffering From COVID-19 Disease The ANTI-CO Trial
NCT04445935 ·Status: UNKNOWN ·Phase: PHASE4
-
Feasibility Study of Hematology Parameters in COVID-19 Disease
NCT04816630 ·Status: COMPLETED
-
Safety in Convalescent Plasma Transfusion to COVID-19
NCT04333355 ·Status: TERMINATED ·Phase: PHASE1
-
The Early Coagulopathy for the Prognosis in Sepsis
NCT04582188 ·Status: UNKNOWN
-
Impact of COVID-19 on the Incidence, Characteristics, Management and Outcome of Sepsis
NCT04698382 ·Status: WITHDRAWN
-
Steroids and Unfractionated Heparin in Critically Ill Patients With Pneumonia From COVID-19 Infection
NCT04528888 ·Status: UNKNOWN ·Phase: PHASE3
-
Viscoelastic Coagulation for Early Sepsis Detection
NCT07073456 ·Status: RECRUITING
-
Circulatory Coherence in COVID-19 and Non-COVID-19 Patients With Sepsis
NCT04644302 ·Status: COMPLETED
-
Coagulation Disturbances in COVID-19 Septic Patients
NCT05496816 ·Status: COMPLETED
-
Fibrinolysis Resistance in Infection and Trauma
NCT06680180 ·Status: RECRUITING
-
Predictive Biomarkers of Secondary Aggravation in Covid-19 Suspect Patient
NCT04341792 ·Status: COMPLETED
-
Early Tranexamic Acid and Modulating the Inflammatory Response in Sepsis
NCT04910464 ·Status: RECRUITING ·Phase: PHASE3
-
TriVerity in the Diagnosis and Prognosis of Emergency Department Patients With Suspected Infections and Suspected Sepsis
NCT04094818 ·Status: COMPLETED
-
Assessment of Endothelial and Haemostatic Changes During Severe SARS-CoV-2 Infection
NCT04357847 ·Status: UNKNOWN
-
Registry of CytoSorb Therapy in COVID-19 ICU Patients
NCT04391920 ·Status: COMPLETED
-
Statin for Immunomudulation in Sepsis
NCT00452608 ·Status: UNKNOWN ·Phase: PHASE2
-
ProAdrenomedullin Assessment of Multi-Organ Failure in COvid-19 Sepsis
NCT04522310 ·Status: COMPLETED
-
Convalescent Plasma Therapy for Hospitalized Patients With COVID-19
NCT05077930 ·Status: COMPLETED ·Phase: PHASE2
-
Variation IGFBP7 Markers and TIMP2 Induced by Injection of Contrast Iodized Drug at the Intensive Care Patient
NCT02881710 ·Status: COMPLETED
-
A Study to Learn About the Occurrence of Disseminated Intravascular Coagulation in People With Sepsis and Further Worsening of Sepsis
NCT06986798 ·Status: COMPLETED ·Phase: NA
-
Plasma Exchange (PLEX) and Convalescent Plasma (CCP) in COVID-19 Patients With Multiorgan Failure
NCT04634422 ·Status: UNKNOWN ·Phase: NA
-
Data Analysis of the Cytokine Adsorption Treatment on Coronavirus Disease-19 (COVID-19) Patients With Respiratory Failure
NCT04422626 ·Status: WITHDRAWN
-
Procurement of Human Specimens for the Evaluation of Early Markers of Sepsis
NCT01746407 ·Status: COMPLETED
-
A Multicenter Prospective Observational Study to Derive and Verify the Performance of a Host-response Based Diagnostic Tool for Early Detection of Severe Infections.
NCT06665542 ·Status: ACTIVE_NOT_RECRUITING
-
Near Patient Molecular Testing in Sepsis
NCT05469048 ·Status: COMPLETED